Divergent BRAF Inhibitor Resistance Mechanisms Revealed through Epigenetic Mapping.
J Invest Dermatol
; 143(5): 842-853.e6, 2023 05.
Article
in En
| MEDLINE
| ID: mdl-36529262
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Proto-Oncogene Proteins B-raf
/
Melanoma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Invest Dermatol
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos